rosiglitazone has been researched along with Calcinosis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Bruedigam, C; Leeuwen, JPTMV; Peppel, JV | 1 |
Cai, Y; Chang, JR; Guan, YF; Jia, MZ; Peng, DQ; Qi, YF; Tang, CS; Wu, W; Yu, YR; Zhang, J; Zhou, YB | 1 |
Abchee, AB; Alam, S; Ayach, K; Dakik, HA; Mehio-Sibai, A; Nasrallah, A; Sawaya, J; Sibai, T; Skouri, HN; Wehbeh, C | 1 |
3 other study(ies) available for rosiglitazone and Calcinosis
Article | Year |
---|---|
Gene Expression Analyses in Models of Rosiglitazone-Induced Physiological and Pathological Mineralization Identify Novel Targets to Improve Bone and Vascular Health.
Topics: Adaptor Proteins, Signal Transducing; Calcinosis; Cell Differentiation; Gene Expression Profiling; Humans; Muscle, Smooth, Vascular; Nuclear Proteins; Osteogenesis; Rosiglitazone | 2023 |
Peroxisome proliferator-activated receptor γ ligands retard cultured vascular smooth muscle cells calcification induced by high glucose.
Topics: Anilides; Animals; Biomarkers; Calcinosis; Cells, Cultured; Chromans; Dose-Response Relationship, Drug; Gene Expression Regulation; Glucose; Ligands; Male; Muscle, Smooth, Vascular; Osteoblasts; Phenotype; PPAR gamma; Rats; Rats, Wistar; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Troglitazone; Vasoconstriction | 2013 |
Prevalence of coronary artery calcium among asymptomatic men and women in a developing country: comparison with the USA data.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Calcinosis; Calcium; Comorbidity; Coronary Artery Disease; Coronary Vessels; Developing Countries; Diabetes Mellitus, Type 2; Female; Humans; Hypercholesterolemia; Hypertension; Hypertriglyceridemia; Lebanon; Male; Middle Aged; Prevalence; Risk Factors; Rosiglitazone; Smoking; Thiazolidinediones; Tomography, X-Ray Computed; United States | 2005 |